Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|January 8, 2023
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer DiagnosisBegoña Jiménez-Rodríguez, Alfonso Alba-Bernal, Esperanza López-López, et al.
Science Advances|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancerAnna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast CancerMohammadA Sabbaghi, Gabriel Gil-Gómez, Cristina Guardia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2019
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversionAna Lluch, Ana M González-Angulo, David Casadevall, et al.
Oncotarget|June 15, 2018
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapyAngela Santonja, Alfonso Sánchez-Muñoz, Ana Lluch, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Scientific Reports|March 9, 2019
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM studyVirginia Lope, Miguel Martín, Adela Castelló, et al.
Plos One|May 16, 2015
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control StudyAdela Castelló, Miguel Martín, Amparo Ruiz, et al.
Gynecologic Oncology|January 7, 2017
Physical activity and breast cancer risk by pathological subtypeVirginia Lope, Miguel Martín, Adela Castelló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 InhibitorsAngel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|January 8, 2023
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer DiagnosisBegoña Jiménez-Rodríguez, Alfonso Alba-Bernal, Esperanza López-López, et al.
Science Advances|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancerAnna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast CancerMohammadA Sabbaghi, Gabriel Gil-Gómez, Cristina Guardia, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2019
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversionAna Lluch, Ana M González-Angulo, David Casadevall, et al.
Oncotarget|June 15, 2018
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapyAngela Santonja, Alfonso Sánchez-Muñoz, Ana Lluch, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Scientific Reports|March 9, 2019
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM studyVirginia Lope, Miguel Martín, Adela Castelló, et al.
Plos One|May 16, 2015
Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control StudyAdela Castelló, Miguel Martín, Amparo Ruiz, et al.
Gynecologic Oncology|January 7, 2017
Physical activity and breast cancer risk by pathological subtypeVirginia Lope, Miguel Martín, Adela Castelló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 InhibitorsAngel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Pageof 19